SCHEMBL22947463

SCHEMBL22947463

Brc1ccc2c(c1)S(c1cccc3ccccc13)(c1cccc3ccccc13)c1ccccc1-2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.37
PTPRC P08575 1/20 0.36
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
CYP1A2 P05177 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
CA2 P00918 2/20 0.34
CA1 P00915 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947450 0.97 CYP2A6 (0.39) CYP2A6PTPRCALDH1A1HPGDCYP1A2
SCHEMBL22947648 0.91 KMT2A (0.33) CYP2A6PTPRCALDH1A1HPGDCYP1A2
SCHEMBL22947360 0.88 CYP2A6 (0.35) CYP2A6PTPRCALDH1A1HPGDCYP1A2
SCHEMBL22947536 0.77 CYP2A6 (0.50) CYP2A6PTPRCALDH1A1HPGDCYP1A2
SCHEMBL11984775 0.76 PTPRC (0.40) CYP2A6PTPRCALDH1A1CYP1A2CA2
SCHEMBL22947487 0.76 CYP1A2 (0.40) CYP2A6ALDH1A1CYP1A2CA2CA1
SCHEMBL22947708 0.76 CYP1A2 (0.41) CYP2A6ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL21310577 0.75 ALDH1A1 (0.33) CYP2A6ALDH1A1HPGDCYP1A2NPSR1
SCHEMBL22928723 0.75 PTPRC (0.45) CYP2A6PTPRCCYP1A2CA2SMN1; SMN2
SCHEMBL22949668 0.75 MAPT (0.41) ALDH1A1HPGDCYP1A2CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 CYP2A6 1117/4885PTPRC 3228/4885ALDH1A1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.